News Virgin Pulse eyes $3bn merger with HealthComp Digital health and wellness company Virgin Pulse has said it plans to merge with HealthComp, a health benefits administrator, in a $3 billion transaction that would create
News AstraZeneca reveals $50bn investment in US facilities Trump's pharma tariffs haven't appeared yet, but AstraZeneca has joined several of its peers with big investments in US manufacturing and R&D.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face